TB-500 (Thymosin Beta-4) · Research brief

TB-500 IU per Tick Insulin Syringe — Dosing Calculator

Real Peptides Research TeamEditorial

Updated April 22, 20269 min read

60 WORDS

Short answer

A 5mg vial of TB-500 reconstituted with 2mL bacteriostatic water yields 2.5mg per mL—but stating that doesn't tell you how many IU of TB-500 you're drawing when you pull to the fourth tick on a 0.3mL insulin syringe. Most peptide guides stop at 'reconstitute and dose'—they don't explain the tick-level math that determines whether your injection contains 800mcg or 1,200mcg.…

Key takeaways

Each tick on a standard insulin syringe represents 0.01mL (1 IU) of volume—not a fixed mass of TB-500.
TB-500 IU per tick insulin syringe depends entirely on reconstitution concentration: 5mg/mL yields 50mcg per tick, 2.5mg/mL yields 25mcg per tick, 2mg/mL yields 20mcg per tick.
A 5mg TB-500 vial reconstituted with 2mL bacteriostatic water (2.5mg/mL) requires pulling to the 20th tick to obtain a 500mcg dose.
Insulin syringes measure volume only—calculating dose requires knowing both your target dose in micrograms and your reconstitution concentration in mcg/mL.
Real Peptides' small-batch synthesis and third-party purity verification ensure that labelled peptide mass matches actual vial content, eliminating a major source of dosing error.
Switching reconstitution volumes mid-protocol without recalculating tick counts can halve or double your intended dose with no visible indication.

Our team at Real Peptides works with research institutions that run protocols requiring exact peptide dosing across multi-week studies. The most common reconstitution error we see isn't contamination or improper storage—it's researchers who don't calculate TB-500 IU per tick insulin syringe correctly and end up with inconsistent dosing across their entire protocol.

How many IU of TB-500 are in each tick on an insulin syringe?

Each tick on a standard 0.3mL insulin syringe represents 3 IU (0.01mL). The amount of TB-500 in each tick depends entirely on your reconstitution concentration. A 5mg vial reconstituted with 1mL yields 5mg/mL—each tick contains 50mcg TB-500. The same vial reconstituted with 2mL yields 2.5mg/mL—each tick contains 25mcg. Insulin syringes measure volume, not mass—the concentration you create during reconstitution determines how much peptide each tick holds.

TB-500 dosing precision isn't academic preference—it's experimental control. Insulin syringes are volume-measurement tools calibrated in units (IU), where 1 IU equals 0.01mL. The confusion arises because 'units' in insulin dosing (where 1 IU = 1 unit of insulin) differs from volumetric units in peptide reconstitution (where 1 IU = 0.01mL of solution). TB-500 concentration is expressed in milligrams per millilitre (mg/mL)—not in insulin units. This article covers how to calculate TB-500 IU per tick insulin syringe for any reconstitution volume, what tick-count errors do to experimental consistency, and how Real Peptides' small-batch synthesis ensures the labelled dose matches what's actually in the vial.

Understanding Insulin Syringe Tick Measurements for Peptide Dosing

Insulin syringes are marked in increments called 'ticks' or 'unit marks'—each tick on a 0.3mL (30-unit) syringe represents 0.01mL or 1 IU. A 0.5mL (50-unit) syringe uses the same tick size—0.01mL per tick. A 1mL (100-unit) syringe also marks 0.01mL per tick, though some models include half-unit ticks at 0.005mL. The critical insight: these ticks measure volume only—they tell you how much liquid you're drawing, not how much peptide mass that liquid contains.

TB-500 IU per tick insulin syringe calculations require knowing your reconstitution concentration first. Start with the peptide mass in the vial—Real Peptides' TB-500 is supplied as 5mg lyophilised powder per vial. If you add 2mL bacteriostatic water, the resulting concentration is 5mg ÷ 2mL = 2.5mg/mL. Now convert milligrams to micrograms (1mg = 1,000mcg): 2.5mg/mL = 2,500mcg/mL. Each 0.01mL tick contains 2,500mcg/mL × 0.01mL = 25mcg TB-500. Pull to the 10th tick (0.1mL) and you've drawn 250mcg.

Researchers who skip this calculation and assume 'ten ticks equals one dose' introduce massive variability. A protocol calling for 500mcg TB-500 twice weekly requires pulling to the 20th tick when reconstituted at 2.5mg/mL—but only the 10th tick if reconstituted at 5mg/mL (1mL water added). Using the wrong tick count can halve your intended dose without any visual indication that something's wrong. The solution sits clear in both cases—appearance doesn't reveal concentration.

TB-500 Reconstitution: How Water Volume Changes Tick Concentration

Reconstitution volume directly determines how many micrograms of TB-500 each tick holds. The same 5mg TB-500 vial produces three different concentrations depending on how much bacteriostatic water you add: 1mL yields 5mg/mL (50mcg per tick), 2mL yields 2.5mg/mL (25mcg per tick), and 2.5mL yields 2mg/mL (20mcg per tick). Each option is correct—but only one matches your protocol's dosing requirements.

Most research protocols specify TB-500 doses in milligrams or micrograms—not in tick counts or insulin units. A typical tissue repair study might call for 2mg TB-500 administered twice weekly over four weeks. Using a 5mg vial reconstituted with 2mL water (2.5mg/mL), that 2mg dose equals 0.8mL—which is 80 ticks on an insulin syringe. A 0.3mL syringe holds only 30 ticks maximum, so you'd need to use a 1mL syringe to draw the full dose in one pull. Alternatively, reconstitute with 1mL water instead (5mg/mL)—now 2mg equals 0.4mL or 40 ticks, which fits in a 0.5mL syringe.

The math: Dose (mcg) = Concentration (mcg/mL) × Volume (mL). Rearrange to find volume: Volume (mL) = Dose (mcg) ÷ Concentration (mcg/mL). Convert mL to ticks by multiplying by 100 (since 0.01mL = 1 tick). Example: 500mcg dose at 2.5mg/mL (2,500mcg/mL) = 500 ÷ 2,500 = 0.2mL = 20 ticks. Write this formula on your protocol sheet—calculating TB-500 IU per tick insulin syringe manually every time introduces transcription errors.

Calculating TB-500 Dose Per Tick: Step-by-Step for Common Concentrations

Here's the exact calculation for TB-500 IU per tick insulin syringe across the three most common reconstitution concentrations researchers use with 5mg vials:

5mg TB-500 + 1mL bacteriostatic water = 5mg/mL (5,000mcg/mL)

Each tick (0.01mL) contains: 5,000mcg/mL × 0.01mL = 50mcg TB-500
10 ticks = 500mcg | 20 ticks = 1,000mcg (1mg) | 40 ticks = 2,000mcg (2mg)

5mg TB-500 + 2mL bacteriostatic water = 2.5mg/mL (2,500mcg/mL)

Each tick (0.01mL) contains: 2,500mcg/mL × 0.01mL = 25mcg TB-500
10 ticks = 250mcg | 20 ticks = 500mcg | 40 ticks = 1,000mcg (1mg) | 80 ticks = 2,000mcg (2mg)

5mg TB-500 + 2.5mL bacteriostatic water = 2mg/mL (2,000mcg/mL)

Each tick (0.01mL) contains: 2,000mcg/mL × 0.01mL = 20mcg TB-500
10 ticks = 200mcg | 25 ticks = 500mcg | 50 ticks = 1,000mcg (1mg) | 100 ticks = 2,000mcg (2mg)

The 2mL reconstitution (2.5mg/mL) is the most common choice—it allows multi-week dosing from a single vial while keeping individual draws under 1mL. A four-week protocol dosing 500mcg twice weekly (eight total doses) requires 4mg TB-500 total—one 5mg vial covers the full protocol with 1mg remaining. Each 500mcg dose pulls to the 20th tick when reconstituted at 2.5mg/mL. Switching to 1mL reconstitution (5mg/mL) would reduce each dose to 10 ticks—easier to measure but the vial empties faster, requiring a second vial mid-protocol.

TB-500 IU per Tick Insulin Syringe: Comparison by Reconstitution Volume

Reconstitution Volume	Final Concentration	TB-500 per Tick (0.01mL)	Ticks for 500mcg Dose	Ticks for 1mg Dose	Ticks for 2mg Dose	Best Use Case
1mL bacteriostatic water	5mg/mL (5,000mcg/mL)	50mcg	10 ticks	20 ticks	40 ticks	Short protocols requiring small, frequent doses; minimises injection volume
2mL bacteriostatic water	2.5mg/mL (2,500mcg/mL)	25mcg	20 ticks	40 ticks	80 ticks	Standard multi-week protocols; balances dose precision with vial longevity
2.5mL bacteriostatic water	2mg/mL (2,000mcg/mL)	20mcg	25 ticks	50 ticks	100 ticks	Extended protocols with moderate doses; maximises draws per vial at cost of larger injection volumes

Higher concentrations (1mL reconstitution) allow smaller injection volumes—beneficial when injection site tolerance is a concern or when administering multiple compounds in sequence. Lower concentrations (2.5mL reconstitution) extend the number of doses per vial and reduce measurement error at low dose ranges—a 200mcg dose is easier to measure accurately as 10 ticks at 2mg/mL than as 4 ticks at 5mg/mL. The trade-off: lower concentrations require more total liquid per dose, which may be unsuitable for protocols with strict volume limits.

What If: TB-500 Dosing Scenarios

What If I Accidentally Add the Wrong Volume of Water During Reconstitution?

Recalculate your concentration immediately using the actual volume added, then adjust your tick count accordingly. If you intended 2mL but added 2.5mL to a 5mg vial, your concentration is now 2mg/mL (not 2.5mg/mL)—each tick holds 20mcg instead of 25mcg. A 500mcg dose now requires 25 ticks instead of 20. Do not attempt to compensate by drawing 'extra' ticks based on visual estimation—use the recalculated number. Mark the vial with the actual concentration to prevent repeated errors across the protocol.

What If My Syringe Doesn't Have Enough Ticks for My Full Dose?

Use a larger syringe or split the dose across two injections administered at different sites. A 2mg dose at 2.5mg/mL concentration requires 80 ticks (0.8mL)—a 0.3mL syringe maxes out at 30 ticks. Switch to a 1mL insulin syringe, which holds 100 ticks. Alternatively, reconstitute with less water to increase concentration: adding 1mL instead of 2mL doubles the concentration to 5mg/mL, reducing the 2mg dose to 40 ticks. Splitting doses works but introduces injection-site variability—single-site administration is preferred when syringe capacity allows.

What If I'm Unsure Whether I Drew the Correct Number of Ticks?

Expel the solution back into the vial and redraw—repeating the draw is safer than guessing. Needle reuse within the same vial during a single reconstitution session does not meaningfully increase contamination risk when using proper aseptic technique. If uncertainty persists across multiple attempts, the issue is usually lighting or syringe angle—hold the syringe at eye level against a white background and count ticks aloud. Persistent measurement difficulty suggests switching to a syringe with clearer tick marks or using a lower concentration to reduce the total tick count required.

The Blunt Truth About TB-500 IU per Tick Insulin Syringe Calculations

Here's the honest answer: most peptide dosing errors happen because researchers assume 'units' on an insulin syringe correspond to peptide dose—they don't. Insulin syringes measure volume in 0.01mL increments, labelled as 'units' because that's how insulin dosing works (1 unit insulin = 0.01mL of standard U-100 insulin). That unit system is irrelevant to TB-500. You're not dosing 'units of TB-500'—you're dosing micrograms of TB-500 dissolved in a specific volume of water. The syringe is a volume-measurement tool, nothing more. Every single TB-500 IU per tick insulin syringe question we field comes back to this: you cannot determine peptide dose from tick marks without knowing your reconstitution concentration first. The ticks stay the same—0.01mL each, always—but what's in that 0.01mL changes completely depending on how much water you added to the vial.

We've worked with researchers who ran entire multi-week protocols at half their intended TB-500 dose because they calculated ticks based on a 1mL reconstitution but actually used 2mL. The study data looked fine—consistent measurements, no visible issues—but the effective dose was 1mg instead of 2mg across every injection. That's not a minor variance; that's a different study. Peptide research demands this level of precision not because we're perfectionists but because dose-response relationships in biological systems are steep. A 50% dose reduction can shift results from statistically significant to undetectable. If your protocol specifies 500mcg TB-500 twice weekly, delivering 250mcg instead isn't 'close enough'—it's a different experimental condition entirely.

Why Peptide Purity Affects Tick-Count Accuracy More Than Most Researchers Realise

Calculating TB-500 IU per tick insulin syringe assumes the vial contains exactly what the label states—but peptide purity varies dramatically across suppliers. A vial labelled '5mg TB-500' from an unverified source might contain 4.2mg, 5.3mg, or anything in between depending on synthesis quality and lyophilisation efficiency. That variance propagates through every calculation: if you reconstitute assuming 5mg but the vial actually holds 4mg, every tick delivers 20% less peptide than your math predicts. You'll complete your protocol thinking you dosed correctly—but the actual administered dose was systematically low across every injection.

Real Peptides addresses this through small-batch synthesis with amino-acid sequencing verified at each production run and third-party purity testing via HPLC (high-performance liquid chromatography). Our TB-500 peptide ships with a certificate of analysis showing actual peptide content per vial—not a generic 'approximately 5mg' label. When your calculation assumes 5mg and the vial genuinely contains 5mg within ±2% tolerance, your tick-count math holds across the entire protocol. That consistency matters more in long-duration studies where cumulative dose accuracy determines whether results replicate. Other high-purity research peptides like Thymalin and Dihexa follow the same small-batch verification process—our focus is eliminating the purity variable so your experimental controls remain tight.

Peptide dosing precision isn't optional. If your reconstitution math assumes a labelled dose that doesn't match the vial's actual content, every tick-count calculation downstream is wrong by the same percentage—and you won't know until you compare study outcomes to published data and find unexplained discrepancies. Using verified-purity peptides costs more upfront but eliminates the largest uncontrolled variable in dose calculation: whether the vial contains what you think it does.

If you're calculating TB-500 IU per tick insulin syringe for research that demands reproducible dosing across multi-week protocols, start with peptides where the labelled concentration matches what's actually in the vial. Count the ticks twice, calculate once, and mark every reconstituted vial with the final concentration and the date mixed. Peptide research depends on controlling variables you can measure—dose accuracy is one of the few you have complete control over from the start.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Each tick on an insulin syringe represents 0.01mL of volume, not a fixed amount of TB-500. The amount of TB-500 per tick depends entirely on your reconstitution concentration. If you reconstitute a 5mg TB-500 vial with 2mL bacteriostatic water (yielding 2.5mg/mL), each tick contains 25mcg TB-500. If you use 1mL water instead (yielding 5mg/mL), each tick contains 50mcg. The ticks measure volume only—you must calculate concentration first to determine peptide mass per tick.

The 2mL reconstitution (producing 2.5mg/mL) is the most commonly used because it balances dose precision with vial longevity. At this concentration, a 500mcg dose requires 20 ticks, a 1mg dose requires 40 ticks, and a 2mg dose requires 80 ticks. Using 1mL water (5mg/mL) reduces tick counts by half but depletes the vial faster. Using 2.5mL water (2mg/mL) extends the vial life but requires larger injection volumes and more ticks per dose.

A 0.3mL (30-unit) insulin syringe works only for doses requiring 30 ticks or fewer. At 2.5mg/mL concentration, this limits you to 750mcg per draw—adequate for protocols dosing 500mcg or less per injection. Doses of 1mg or higher require either a 0.5mL or 1mL syringe, or splitting the dose across two injections. For protocols requiring 2mg doses (80 ticks at 2.5mg/mL), you must use a 1mL syringe or reconstitute at higher concentration to reduce the required tick count.

Dosing errors from incorrect tick calculations produce systematic under-dosing or over-dosing across your entire protocol. If you calculate ticks assuming 5mg/mL concentration but actually reconstituted at 2.5mg/mL, every injection delivers half your intended dose—a 500mcg target becomes 250mcg. This isn’t a minor variance; it’s a different experimental dose entirely. Over-dosing by the same margin wastes expensive peptide and may push doses into ranges not validated by existing research. Always recalculate tick count if you change reconstitution volumes mid-protocol.

Without access to HPLC (high-performance liquid chromatography) or mass spectrometry, you cannot verify peptide content at home—visual inspection and solubility do not indicate purity or mass. Reputable suppliers like Real Peptides provide certificates of analysis showing third-party verification of peptide content per vial. If your supplier does not provide batch-specific purity data, you’re calculating TB-500 IU per tick insulin syringe based on an assumed concentration that may not match the actual vial contents, introducing uncontrolled error into every dose.

Milligrams (mg) and micrograms (mcg) measure the same thing at different scales: 1mg = 1,000mcg. Protocols use milligrams for larger doses (1mg, 2mg) because the numbers are simpler to state, and micrograms for smaller doses (250mcg, 500mcg) to avoid fractional milligram notation. When calculating TB-500 IU per tick insulin syringe, always convert your target dose to micrograms before dividing by concentration—this eliminates decimal errors. A 2mg dose equals 2,000mcg; a 500mcg dose equals 0.5mg.

Pre-filling syringes is not recommended for peptides due to stability concerns. Once TB-500 is reconstituted, it should remain refrigerated at 2–8°C in the original vial with a sterile rubber stopper. Peptides stored in plastic syringes degrade faster due to adsorption onto syringe walls and loss of the sterile seal. Draw each dose immediately before administration—the 30 seconds required to draw and verify tick count does not justify the stability risk of pre-filled storage.

U-100 insulin syringes are calibrated for U-100 insulin (100 units insulin per mL), but when used for TB-500, they function as standard volumetric syringes where each unit mark equals 0.01mL—the ‘U-100’ designation becomes irrelevant. Some peptide suppliers sell ‘peptide reconstitution syringes’ with identical 0.01mL graduations but without unit markings—they’re functionally the same tool. The key is that each tick represents 0.01mL of volume regardless of what the syringe was originally designed to measure. U-40 or U-50 insulin syringes use different calibrations and should not be used for peptide dosing without recalculating tick volume.

Reconstituted TB-500 stored at 2–8°C in bacteriostatic water maintains stability for approximately 28 days, after which peptide degradation accelerates and dose accuracy declines. For protocols extending beyond four weeks, reconstitute a fresh vial rather than continuing to draw from an aging solution—degraded peptide delivers lower effective doses even if your tick count remains correct. Freezing reconstituted TB-500 extends stability but requires single-use aliquots to avoid freeze-thaw cycles, which denature peptide structure. Most research protocols are designed to consume one vial within 28 days to avoid stability-related dose variance.

TB-500 research doses vary widely depending on study design, ranging from 200mcg daily for localised tissue studies to 2mg twice weekly for systemic healing protocols. There is no universal ‘standard dose’—each protocol specifies doses based on the biological endpoint being measured and the subject population. When calculating TB-500 IU per tick insulin syringe, always start with the dose specified in your approved research protocol and work backward to determine the tick count required at your chosen reconstitution concentration. Using doses from unrelated studies introduces uncontrolled variables that compromise experimental validity.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA